Abstract 5866: Preclinical combination approaches with the pan-KRAS inhibitor AMG 410 in KRAS- mutant cancers
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Amgen (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148857201
